Тезисы titul indd

List of references: 
1.
Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. 
Nature 1993;362(6423):801-9. 
2.
Libby P, Ridker PM, Hansson GK. Progress and challenges in 
translating the biology of atherosclerosis. Nature 2011;473:317-25. 
3.
Grad E, Danenberg HD. C-reactive protein and atherothrombosis: Cause 
or effect? Blood Rev 2013;27(1):23-9. 
4.
Casas JP, Shah T, Hingorani AD, Danesh J, Pepys MB. C-reactive 
protein and coronary heart disease: A critical review. J Intern Med 2008;264:295-
314. 
5.
Ridker PM. Clinician’s guide to reducing inflammation to reduce 
atherothrombotic risk: JACC review topic of the week. J Am Coll Cardiol 
2018;72:3320-31. 
6.
Atlas Writing Group, Timmis A, Townsend N, Gale C, Grobbee R, 
Maniadakis N, Flather M, et al. European Society of Cardiology: cardiovascular 
disease statistics 2017. Eur Heart J 2018; 39(7):508-79. 
7.
Piepoli MF, Hoes AW, Agewall S, Albus C, Brotons C, Catapano AL, et 
al. 2016 European guidelines on cardiovascular disease prevention in clinical 
practice: the sixth joint task force of the European Society of Cardiology and other 

---

7 
societies on cardiovascular disease prevention in clinical practice (constituted by 
representatives of 10 societies and by invited experts) developed with the special 
contribution of the European Association for Cardiovascular Prevention & 
Rehabilitation (EACPR). Eur Heart J 2016; 37: 2315-81. 
8.
Janković J, Davidović M, Bjegović-Mikanović V, Janković. Status of 
cardiovascular health in the Republic of Serbia: Results from the National Health 
Survey. PLoS One 2019;14(3): e0214505 
9.
Arnett DK, Blumenthal RS, Albert MA, et al. 2019 ACC/AHA guideline 
on the primary prevention of cardiovascular disease: a report of the American 
College of Cardiology/American Heart Association task force on clinical practice 
guidelines. J Am Coll Cardiol 2019; 74(10). 
10.
Wang A, et al., Cumulative exposure to high-sensitivity C-reactive 
protein predicts the risk of cardiovascular disease, J Am Heart Assoc 2017;6(10): 
e005610. 
11.
Pagidipati NJ, et al. High-sensitivity C-reactive protein elevation in 
patients with prior myocardial infarction in the United States. Am Heart J 2018; 
204:151-5. 
12.
Yousuf O, Mohanty BD, Martin SS, et al
. 
High-sensitivity C-reactive 
protein and cardiovascular disease: a resolute belief or an elusive link. J Am Coll 
Cardiol 2013; 62: 397-408.